| Citation: |
GONG Jin, ZHANG Jinjin, CHEN Lili, WANG Hui, XING Yanchao. Research Progress on Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 75-82. DOI: 10.12290/xhyxzz.2024-1049
|
Knee osteoarthritis (KOA) is a prevalent degenerative joint disease characterized by synovial inflammation, cartilage loss. Often manifesting as joint pain and limited mobility, it severely affects the quality of life of patients. Traditional treatment methods such as pharmacological injections and surgical interventions primarily aim to alleviate symptoms but have limited effects on cartilage repair. Human umbilical cord mesenchymal stem cells (hUC-MSCs), due to their anti-inflammatory and chondrogenic capabilities, is considered a new hope for the treatment of KOA. This article synthesizes the latest research findings from both domestic and international sources to discuss the theoretical basis for the clinical application of hUC-MSCs in treating KOA, clinical study design, and efficacy evaluation. It also addresses the challenges in the clinical application of hUC-MSCs and explores future directions, in the hope of providing feasible theoretical support for the treatment of KOA with hUC-MSCs.
| [1] |
龚恒, 陈连旭, 黄斌. 关节内注射间充质干细胞治疗退行性膝骨关节炎临床研究进展[J]. 中国运动医学杂志, 2020, 39(9): 746-750. DOI: 10.3969/j.issn.1000-6710.2020.09.012
Gong H, Chen L X, Huang B. Clinical research progress on intra-articular injection of mesenchymal stem cells for the treatment of degenerative knee osteoarthritis[J]. Chin J Sports Med, 2020, 39(9): 746-750. DOI: 10.3969/j.issn.1000-6710.2020.09.012
|
| [2] |
Wu Q L, Wu Z Q, Lu Z F. Clinical efficacy and safety of the combination of mesenchymal stem cells and scaffolds in the treatment of knee osteoarthritis: protocol for systematic review and meta-analysis[J]. Medicine (Baltimore), 2022, 101(43): e31638. DOI: 10.1097/MD.0000000000031638
|
| [3] |
Xu X, Xu L M, Xia J, et al. Harnessing knee joint resident mesenchymal stem cells in cartilage tissue engineering[J]. Acta Biomater, 2023, 168: 372-387. DOI: 10.1016/j.actbio.2023.07.024
|
| [4] |
Chu H S, Zhang S Y, Zhang Z L, et al. Comparison studies identify mesenchymal stromal cells with potent regenerative activity in osteoarthritis treatment[J]. NPJ Regen Med, 2024, 9(1): 14. DOI: 10.1038/s41536-024-00358-y
|
| [5] |
中华医学会骨科学分会关节外科学组, 解放军总医院第四医学中心骨科医学部, 国家骨科与运动康复临床医学研究中心. 中国膝骨关节炎非手术治疗专家共识(2023年版)[J]. 中华关节外科杂志(电子版), 2024, 18(2): 151-159.
Joint Surgery Group of Chinese Medical Association, Senior Department of Orthopedics, the Forth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation. Chinese expert consensus in non-surgical management of knee osteoarthritis[J]. Chin J Joint Surg (Electron Ed), 2024, 18(2): 151-159.
|
| [6] |
Suh K, Cole B J, Gomoll A, et al. Cost effectiveness of allogeneic umbilical cord blood-derived mesenchymal stem cells in patients with knee osteoarthritis[J]. Appl Health Econ Health Policy, 2023, 21(1): 141-152. DOI: 10.1007/s40258-022-00762-9
|
| [7] |
Li Y F, Zhang Y N, Wang H, et al. Dental pulp mesenchymal stem cells attenuate limb ischemia via promoting capillary proliferation and collateral development in a preclinical model[J]. Stem Cells Int, 2021, 2021: 5585255.
|
| [8] |
Li B, Cheng Y, Yu S Y, et al. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates nonal-coholic fatty liver disease in obese type 2 diabetic mice[J]. Stem Cells Int, 2019, 2019: 8628027.
|
| [9] |
Arderiu G, Civit-Urgell A, Badimon L. Adipose-derived stem cells to treat ischemic diseases: the case of peripheral artery disease[J]. Int J Mol Sci, 2023, 24(23): 16752. DOI: 10.3390/ijms242316752
|
| [10] |
Ryu D J, Jeon Y S, Park J S, et al. Comparison of bone marrow aspirate concentrate and allogenic human umbilical cord blood derived mesenchymal stem cell implantation on chondral defect of knee: assessment of clinical and magnetic resonance imaging outcomes at 2-year follow-up[J]. Cell Transplant, 2020, 29: 963689720943581.
|
| [11] |
Li Z T, Wang Y M, Wang H, et al. Self-assembled DNA composite-engineered mesenchymal stem cells for improved skin-wound repair[J]. Small, 2024, 20(31): 2310241. DOI: 10.1002/smll.202310241
|
| [12] |
Xie H C, Wang Z G, Feng Y H, et al. Bone marrow mesenchymal stem cells repress renal transplant immune rejection by facilitating the APRIL phosphorylation to induce regulation B cell production[J]. Physiol Genomics, 2023, 55(2): 90-100. DOI: 10.1152/physiolgenomics.00103.2022
|
| [13] |
Yalçin M B, Bora E S, Erdoğan M A, et al. The effect of adipose-derived mesenchymal stem cells on peripheral nerve damage in a rodent model[J]. J Clin Med, 2023, 12(19): 6411. DOI: 10.3390/jcm12196411
|
| [14] |
Fan M Q, Zhang J W, Zhou L, et al. Intra-articular injection of placental mesenchymal stromal cells ameliorates pain and cartilage anabolism/catabolism in knee osteoarthritis[J]. Front Pharmacol, 2022, 13: 983850. DOI: 10.3389/fphar.2022.983850
|
| [15] |
Sadri B, Tamimi A, Nouraein S, et al. Clinical and laboratory findings following transplantation of allogeneic adipose-derived mesenchymal stromal cells in knee osteoarthritis, a brief report[J]. Connect Tissue Res, 2022, 63(6): 663-674. DOI: 10.1080/03008207.2022.2074841
|
| [16] |
He S, Zhang J, Chen W J, et al. Umbilical cord mesenchymal stem cells promote the repair of trochlear groove reconstruction in dogs[J]. Front Vet Sci, 2022, 9: 922390. DOI: 10.3389/fvets.2022.922390
|
| [17] |
Lim H C, Park Y B, Ha C W, et al. Allogeneic umbilical cord blood-derived mesenchymal stem cell implantation versus microfracture for large, full-thickness cartilage defects in older patients: a multicenter randomized clinical trial and extended 5-year clinical follow-up[J]. Orthop J Sports Med, 2021, 9(1): 2325967120973052. DOI: 10.1177/2325967120973052
|
| [18] |
Kim K I, Lee W S, Kim J H, et al. Safety and efficacy of the intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritic knee: a 5-year follow-up study[J]. Stem Cells Transl Med, 2022, 11(6): 586-596. DOI: 10.1093/stcltm/szac024
|
| [19] |
BANERJI B. Allogenic human umbilical cord derived mesenchymal stem cells for managing knee osteoarthritis in human-a clinical trial[J]. J Regen Biol Med, 2021, 3(5): 1-15.
|
| [20] |
Hori A, Takahashi A, Miharu Y, et al. Superior migration ability of umbilical cord-derived mesenchymal stromal cells (MSCs) toward activated lymphocytes in comparison with those of bone marrow and adipose-derived MSCs[J]. Front Cell Dev Biol, 2024, 12: 1329218. DOI: 10.3389/fcell.2024.1329218
|
| [21] |
Lubis A M T, Situmeang A, Canintika A F, et al. Intra-articular injection of human umbilical cord-derived mesen-chymal stem cells in sheep models of meniscectomy-induced osteoarthritis: an experimental study[J]. Orthop J Sports Med, 2023, 11(S2): 2325967121S00913.
|
| [22] |
Tong W, Zhang X G, Zhang Q, et al. Multiple umbilical cord-derived MSCs administrations attenuate rat osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitis[J]. J Orthop Translat, 2020, 23: 21-28. DOI: 10.1016/j.jot.2020.03.007
|
| [23] |
Tian H, Tong W, Zhang X, et al. Umbilical cord derived mesenchymal stem cells attenuate rodent Osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitis[J]. Osteoarthritis Cartilage, 2020, 28(S1): S513-S514.
|
| [24] |
Lee N H, Na S M, Ahn H W, et al. Allogenic human umbilical cord blood-derived mesenchymal stem cells are more effective than bone marrow aspiration concentrate for cartilage regeneration after high tibial osteotomy in medial unicompartmental osteoarthritis of knee[J]. Arthroscopy, 2021, 37(8): 2521-2530. DOI: 10.1016/j.arthro.2021.02.022
|
| [25] |
Zhou Y, Zhao Y J, Wu Y J, et al. Human umbilical cord mesenchymal stem cells alleviate rat knee osteoarthritis via activating Wnt/β-catenin signaling pathway[J]. Curr Stem Cell Res Ther, 2024, 19(2): 234-244. DOI: 10.2174/1574888X18666230428094400
|
| [26] |
Tang S J, Chen P H, Zhang H R, et al. Comparison of curative effect of human umbilical cord-derived mesenchymal stem cells and their small extracellular vesicles in treating osteoarthritis[J]. Int J Nanomedicine, 2021, 16: 8185-8202. DOI: 10.2147/IJN.S336062
|
| [27] |
Perry J, Roelofs A J, Mennan C, et al. Human mesenchymal stromal cells enhance cartilage healing in a murine joint surface injury model[J]. Cells, 2021, 10(8): 1999. DOI: 10.3390/cells10081999
|
| [28] |
Perry J, McCarthy H S, Bou-Gharios G, et al. Injected human umbilical cord-derived mesenchymal stromal cells do not appear to elicit an inflammatory response in a murine model of osteoarthritis[J]. Osteoarthr Cartil Open, 2020, 2(2): 100044. DOI: 10.1016/j.ocarto.2020.100044
|
| [29] |
Ju Y, Yi L X, Li C, et al. Comparison of biological characteristics of human adipose- and umbilical cord- derived mesenchymal stem cells and their effects on delaying the progression of osteoarthritis in a rat model[J]. Acta Histochem, 2022, 124(6): 151911. DOI: 10.1016/j.acthis.2022.151911
|
| [30] |
Bie Y N, Chen Q Q, Xu J H, et al. Human umbilical-cord-derived mesenchymal stem cells in combination with rapamycin reduce cartilage degradation via inhibition of the AKT/mTOR signaling pathway[J]. Immunopharmacol Immunotoxicol, 2023, 45(5): 549-557. DOI: 10.1080/08923973.2023.2189062
|
| [31] |
Pan X, Li X F, Zhang L, et al. Umbilical cord mesenchymal stem cells relieve osteoarthritis in rats through immunoregulation and inhibition of chondrocyte apoptosis[J]. Sci Rep, 2023, 13(1): 14975. DOI: 10.1038/s41598-023-42349-x
|
| [32] |
Xing D, Wu J, Wang B, et al. Intra-articular delivery of umbilical cord-derived mesenchymal stem cells temporarily retard the progression of osteoarthritis in a rat model[J]. Int J Rheum Dis, 2020, 23(6): 778-787. DOI: 10.1111/1756-185X.13834
|
| [33] |
Nativel F, Smith A, Marquis M, et al. Intra-articular injection of mesenchymal stromal cell encapsulated in micro-molded alginate particles for the treatment of post-traumatic osteoarthritis: preliminary study in rabbit knee[J]. Osteoarthritis Cartilage, 2021, 29(S1): S84.
|
| [34] |
Liu A F, Chen J X, Zhang J T, et al. Intra-articular injection of umbilical cord mesenchymal stem cells loaded with graphene oxide granular lubrication ameliorates inflammatory responses and osteoporosis of the subchondral bone in rabbits of modified papain-induced osteoarthritis[J]. Front Endocrinol (Lausanne), 2021, 12: 822294.
|
| [35] |
Bertoni L, Branly T, Jacquet S, et al. Intra-Articular injection of 2 different dosages of autologous and allogeneic bone marrow- and umbilical cord-derived mesenchymal stem cells triggers a variable inflammatory response of the fetlock joint on 12 sound experimental horses[J]. Stem Cells Int, 2019, 2019: 9431894.
|
| [36] |
Wu J L, Wong P C, Ho C W, et al. Human umbilical cord mesenchymal stem cells in combination with hyaluronic acid ameliorate the progression of knee osteoarthritis[J]. Appl Sci, 2021, 11(14): 6650. DOI: 10.3390/app11146650
|
| [37] |
Wang Y L, Jin W X, Liu H Y, et al. Curative effect of human umbilical cord mesenchymal stem cells by intra-articular injection for degenerative knee osteoarthritis[J]. Chin J Reparative Reconstr Surg, 2016, 30(12): 1472-1477.
|
| [38] |
Matas J, Orrego M, Amenabar D, et al. Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase Ⅰ/Ⅱ trial[J]. Stem Cells Transl Med, 2019, 8(3): 215-224. DOI: 10.1002/sctm.18-0053
|
| [39] |
Park Y, Ha C, Kim J, et al. Allogeneic umbilical cord blood-derived mesenchymal stem cells versus microfracture for large full-thickness cartilage defects[J]. Cytotherapy, 2020, 22(S5): S29-S30.
|
| [40] |
Song J S, Hong K T, Kim N M, et al. Implantation of allogenic umbilical cord blood-derived mesenchymal stem cells improves knee osteoarthritis outcomes: two-year follow-up[J]. Regen Ther, 2020, 14: 32-39. DOI: 10.1016/j.reth.2019.10.003
|
| [41] |
Cole B J, Kaiser J T, Wagner K R, et al. Safety of an allogeneic, human, umbilical cord blood-derived mesenchymal stem cells-4% hyaluronate composite for cartilage repair in the knee[J]. J Cartilage Joint Preserv, 2022, 2(1): 100037. DOI: 10.1016/j.jcjp.2021.100037
|
| [42] |
Samara O, Jafar H, Hamdan M, et al. Ultrasound-guided intra-articular injection of expanded umbilical cord mesenchymal stem cells in knee osteoarthritis: a safety/efficacy study with MRI data[J]. Regen Med, 2022, 17(5): 299-312. DOI: 10.2217/rme-2021-0121
|
| [43] |
Kim Y S, Suh D S, Tak D H, et al. Adipose-derived stromal vascular fractions are comparable with allogenic human umbilical cord blood-derived mesenchymal stem cells as a supplementary strategy of high tibial osteotomy for varus knee osteoarthritis[J]. Arthrosc Sports Med Rehabil, 2023, 5(3): e751-e764. DOI: 10.1016/j.asmr.2023.04.002
|
| [44] |
Ao Y N, Duan J J, Xiong N, et al. Repeated intra-articular injections of umbilical cord-derived mesenchymal stem cells for knee osteoarthritis: a phase Ⅰ, single-arm study[J]. BMC Musculoskelet Disord, 2023, 24(1): 488. DOI: 10.1186/s12891-023-06555-y
|
| [45] |
Mautner K, Gottschalk M, Boden S D, et al. Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial[J]. Nat Med, 2023, 29(12): 3120-3126. DOI: 10.1038/s41591-023-02632-w
|
| [46] |
Park Y B, Lee H J, Nam H C, et al. Allogeneic umbilical cord-blood-derived mesenchymal stem cells and hyaluronate composite combined with high tibial osteotomy for medial knee osteoarthritis with Full-Thickness cartilage defects[J]. Medicina (Kaunas), 2023, 59(1): 148. DOI: 10.3390/medicina59010148
|
| [47] |
Matas J, García C, Poblete D, et al. A phase Ⅰ dose-escalation clinical trial to assess the safety and efficacy of umbilical cord-derived mesenchymal stromal cells in knee osteoarthritis[J]. Stem Cells Transl Med, 2024, 13(3): 193-203.
|
| [48] |
Md Yusoff B A H B, Mohd Don A F B, Mohamad N B, et al. ChondrogenTM injection for knee osteoarthritis using stem cells from Wharton's Jelly[J]. Sains Malaysiana, 2023, 52(10): 2773-2784.
|
| [49] |
赵庆辉, 白志慧, 贾文文, 等. 临床级人脐带间充质干细胞资源库的构建[J]. 国际生物医学工程杂志, 2021, 44(6): 454-459.
Zhao Q H, Bai Z H, Jia W W, et al. Establishment of a clinical grade human umbilical cord mesenchymal stem cells bank[J]. Int J Biomed Eng, 2021, 44(6): 454-459.
|
| [50] |
Kurogi H, Takahashi A, Isogai M, et al. Umbilical cord derived mesenchymal stromal cells in microcarrier based industrial scale culture sustain the immune regulatory functions[J]. Biotechnol J, 2021, 16(6): 2000558.
|
| [51] |
Wang X, Ouyang L M, Chen W X, et al. Efficient expansion and delayed senescence of hUC-MSCs by microcarrier-bioreactor system[J]. Stem Cell Res Ther, 2023, 14(1): 284.
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！
Submit
Review
Office
Email Alert
RSS
DownLoad: